Fate Therapeutics
FATE
Reported
Tuesday, February 28
Q4 2022 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.86 | -0.58 | 0.28 | 32.56% |
| Revenue | 16.7M | 44.4M | 27.6M | 165.29% |
WhatIF - Earnings
EPS Beat Expectations by $0.28
Fate Therapeutics (FATE:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything